Search - tctmd.com

Displaying 161 - 180 of 361

Sort: Relevancy | Date

Optimal Time to Start Anticoagulation After Stroke Remains Unclear

News Conference News ISC 2020

Optimal Time to Start Anticoagulation After Stroke Remains Unclear

February 27, 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

Stroke Thrombectomy for Basilar Artery Occlusions Gains Support: Registry

News Conference News ISC 2020

Stroke Thrombectomy for Basilar Artery Occlusions Gains Support: Registry

February 25, 2020

SKIP Questions Need for IV Thrombolysis Before Stroke Thrombectomy

News Conference News ISC 2020

SKIP Questions Need for IV Thrombolysis Before Stroke Thrombectomy

February 25, 2020

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

News Conference News CRT 2020

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

February 24, 2020

No Need to Go to Higher Tenecteplase Dose for Acute Stroke

News Conference News ISC 2020

No Need to Go to Higher Tenecteplase Dose for Acute Stroke

February 21, 2020

Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It?

News Conference News ISC 2020

Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It?

February 21, 2020

Could Revascularization of Carotid Stenosis Reverse Cognitive Deficits?

News Conference News VEITH 2019

Could Revascularization of Carotid Stenosis Reverse Cognitive Deficits?

November 25, 2019

Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome

News Daily News

Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome

October 15, 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

October 04, 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

News Daily News

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

August 16, 2019

Trial Points to Possible Benefit of Intensive BP-Lowering to Stave Off Recurrent Stroke

News Daily News

Trial Points to Possible Benefit of Intensive BP-Lowering to Stave Off Recurrent Stroke

July 29, 2019

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

June 17, 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

June 13, 2019

New Clarity on Patients at High Risk for Bleeding After PCI

News Conference News EuroPCR 2019

New Clarity on Patients at High Risk for Bleeding After PCI

Michael O'Riordan

May 28, 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

News Conference News ESC Heart Failure 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

May 26, 2019

TCTMD’s Top 10 Most Popular Stories for April 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

May 01, 2019

New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk

News Daily News

New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk

Yael L. Maxwell

April 09, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.